IO BIOTECH INC. - COMMON STOCK
1.1100
20-2月-25 14:27:56
15 分の遅延
株式
+0.1100
+11.00%
本日の幅
0.9593 - 1.1350
ISIN
N/A
ソース
NASDAQ
-
01 6 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
IO Biotech to Present at the Jefferies Healthcare Conference
30 5 2023 15:35:00 提供 Nasdaq GlobeNewswire
-
IO Biotech Announces 2023 First-Quarter Results
11 5 2023 15:05:01 提供 Nasdaq GlobeNewswire
-
IO Biotech Announces 2022 Fourth-Quarter and Year-End Results
14 3 2023 15:11:47 提供 Nasdaq GlobeNewswire
-
IO Biotech to Participate in March 2023 Investor Conferences
22 2 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
IO Biotech Announces Appointment of Devin Smith as General Counsel
23 1 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
IO Biotech Provides Business Update
09 1 2023 06:05:46 提供 Nasdaq GlobeNewswire
-
IO Biotech Announces Third Quarter Results for 2022
09 11 2022 15:05:01 提供 Nasdaq GlobeNewswire
-
IO Biotech to Participate in the Jefferies London Healthcare Conference
31 10 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
IO Biotech Announces Appointment of New Chief Financial Officer
13 10 2022 15:05:00 提供 Nasdaq GlobeNewswire
-
05 10 2022 07:05:00 提供 Nasdaq GlobeNewswire
-
IO Biotech to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
06 9 2022 06:30:00 提供 Nasdaq GlobeNewswire
-
IO Biotech Announces Second Quarter Results for 2022
11 8 2022 16:00:18 提供 Nasdaq GlobeNewswire
-
IO Biotech to Participate in the 2022 BIO International Convention
06 6 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
26 5 2022 16:00:00 提供 Nasdaq GlobeNewswire
-
IO Biotech to Participate in the Jefferies Healthcare Conference
23 5 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
18 5 2022 06:00:00 提供 Nasdaq GlobeNewswire
-
IO Biotech Announces First Quarter Results for 2022
16 5 2022 15:15:00 提供 Nasdaq GlobeNewswire